RxDoctor Payments Data

Victor Villalobos

Medical Oncology · Aurora, CONPI 1861649865

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $22,863 of the $25,584 with a category attached, or 89.4%.

$25,584in general payments, 2019–2025

Across 50 payments — averaging $511.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eli Lilly$15K
  • Daiichi Sankyo Inc.$10K
$587,050in research payments, 2019–2025

Across 61 payments — averaging $9623.77 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Roche Products Limited$276K
  • AbbVie$180K
  • AstraZeneca$52K
  • Eli Lilly$42K
  • Karyopharm Therapeutics Inc.$26K
  • Blueprint Medicines Corporation$11K
  • plus $769 from 1 others

What the payments were for

  • Consulting fees$22,86389%
  • Travel & lodging$2,2969%
  • Food & beverage$4262%

General payments by program year

19
20

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Eli Lilly42$15,162
Daiichi Sankyo Inc.8$10,423

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$25,584 in reported general payments places this provider in the 80th percentile of 96 medical oncology providers in Colorado.

See all medical oncology providers in Colorado

Other medical oncology in Aurora

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →